AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LISATA THERAPEUTICS, INC. Director's Dealing 2017

Mar 23, 2017

34931_dirs_2017-03-23_ce7e5dd3-431b-4457-9420-1c8ec5276521.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2017-03-22

Reporting Person: Sanford (10% Owner)
Reporting Person: Sanford Health (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1059322	Direct